Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6502
    +0.0002 (+0.03%)
     

  • OIL

    82.72
    -0.09 (-0.11%)
     

  • GOLD

    2,329.10
    -9.30 (-0.40%)
     

  • Bitcoin AUD

    99,355.64
    -3,002.60 (-2.93%)
     

  • CMC Crypto 200

    1,390.56
    -33.54 (-2.36%)
     

  • AUD/EUR

    0.6073
    +0.0003 (+0.05%)
     

  • AUD/NZD

    1.0944
    +0.0003 (+0.02%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    37,984.27
    -475.81 (-1.24%)
     

Why Huntsman (HUN) Stock Might be a Great Pick

Zacks Equity Research
Updated

One stock that might be an intriguing choice for investors right now is Huntsman Corporation HUN. This is because this security in the Chemical - Diversified  space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Chemical - Diversified space as it currently has a Zacks Industry Rank of 52 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Huntsman is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

Huntsman Corporation Price and Consensus

Huntsman Corporation Price and Consensus | Huntsman Corporation Quote

ADVERTISEMENT

In fact, over the past month, current quarter estimates have risen from 52 cents per share to 63 cents per share, while current year estimates have risen from $2.61 per share to $2.65 per share. This has helped HUN to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a decent pick in a strong industry, consider Huntsman. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Huntsman Corporation (HUN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.